QGEN logo

QGEN
Qiagen NV

1,415
Mkt Cap
$8.46B
Volume
1.28M
52W High
$57.82
52W Low
$38.13
PE Ratio
20.07
QGEN Fundamentals
Price
$41.03
Prev Close
$40.38
Open
$39.91
50D MA
$46.73
Beta
0.56
Avg. Volume
2.11M
EPS (Annual)
$2.04
P/B
2.24
Rev/Employee
$369,649.63
$10,556.49
Loading...
Loading...
News
all
press releases
Qiagen N.V. (NYSE:QGEN) Given Average Rating of "Hold" by Brokerages
Qiagen N.V. (NYSE:QGEN - Get Free Report) has been assigned an average rating of "Hold" from the twelve research firms that are presently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and five ha...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Allspring Global Investments Holdings LLC Boosts Position in Qiagen N.V. $QGEN
Allspring Global Investments Holdings LLC boosted its position in Qiagen N.V. (NYSE:QGEN - Free Report) by 10.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,164,805 shares of the company's stock after purchasing an additional 290,449 shares du...
MarketBeat·5d ago
News Placeholder
Qiagen (NYSE:QGEN) Cut to "Hold" at Wall Street Zen
Wall Street Zen lowered Qiagen from a "buy" rating to a "hold" rating in a research report on Saturday...
MarketBeat·8d ago
News Placeholder
Qiagen (NYSE:QGEN) Sets New 52-Week Low - Time to Sell?
Qiagen (NYSE:QGEN) Hits New 52-Week Low - Time to Sell...
MarketBeat·9d ago
News Placeholder
JPMorgan Chase & Co. Has $33.09 Million Stake in Qiagen N.V. $QGEN
JPMorgan Chase & Co. reduced its position in Qiagen N.V. (NYSE:QGEN - Free Report) by 40.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 740,649 shares of the company's stock after selling 512,299 shares...
MarketBeat·13d ago
News Placeholder
Qiagen (NYSE:QGEN) Hits New 12-Month Low - Should You Sell?
Qiagen (NYSE:QGEN) Sets New 52-Week Low - Here's Why...
MarketBeat·16d ago
News Placeholder
Qiagen Announces Form 20-F Annual Report Filing for 2025 Results
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended...
Business Wire·16d ago
News Placeholder
QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced newly published clinical and health economic data supporting the use of its QuantiFERON-TB Gold Plus (QFT-Plus) blood test for...
Business Wire·17d ago
News Placeholder
Hologic's Women's Health Index Flags Alarming Gaps in STI Screening
HOLX's Global Women's Health Index shows STI testing stagnates at 10%, leaving nearly 2 billion women at risk despite gains in other screenings.
Zacks·17d ago
News Placeholder
Moors & Cabot Inc. Acquires 154,851 Shares of Qiagen N.V. $QGEN
Moors & Cabot Inc. lifted its stake in Qiagen N.V. (NYSE:QGEN - Free Report) by 78.2% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange...
MarketBeat·19d ago
<
1
2
...
>

Latest QGEN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.